Viveve Medical, Inc. (VIVE): Price and Financial Metrics

Viveve Medical, Inc. (VIVE): $0.00

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

VIVE Price/Volume Stats

Current price $0.00 52-week high $0.11
Prev. close $0.00 52-week low $0.00
Day low $0.00 Volume 100
Day high $0.00 Avg. volume 3,448
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 2.14K

VIVE Stock Price Chart Interactive Chart >


Viveve Medical, Inc. (VIVE) Company Bio


Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company was founded in 2005 and is based in Sunnyvale, California.


VIVE Latest News Stream


Event/Time News Detail
Loading, please wait...

VIVE Latest Social Stream


Loading social stream, please wait...

View Full VIVE Social Stream

Latest VIVE News From Around the Web

Below are the latest news stories about VIVEVE MEDICAL INC that investors may wish to consider to help them evaluate VIVE as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!

William White on InvestorPlace | January 17, 2023

Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and treatment of female stress urinary incontinence, today announced the completion of final 12-month post-treatment follow-up visits in its landmark U.S. PURSUIT clinical trial for the treatment of stress urinary incontinence (SUI) in women. A total of 415 patients were enrolled in the trial, and 342 patients completed 12-month follow-up visits.

Yahoo | December 15, 2022

Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

/ Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of female stress urinary incontinence (SUI), today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11511110 covering Viveve's treatment to address SUI in women. The issuance of the new patent strengthens the Company's intellectual property portfolio in advance of the planned completion of its U.S.

Yahoo | December 1, 2022

Viveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

Viveve Medical ( NASDAQ:VIVE ) Third Quarter 2022 Results Key Financial Results Revenue: US$1.68m (up 4.2% from 3Q...

Yahoo | November 13, 2022

Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of female stress urinary incontinence (SUI), today reported financial results for the quarter ended September 30, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today.

Yahoo | November 10, 2022

Read More 'VIVE' Stories Here

VIVE Price Returns

1-mo 0.00%
3-mo 0.00%
6-mo N/A
1-year 0.00%
3-year 0.00%
5-year 0.00%
YTD 0.00%
2023 -99.95%
2022 -62.72%
2021 -75.74%
2020 -62.70%
2019 -98.80%

Continue Researching VIVE

Want to see what other sources are saying about Viveve Medical Inc's financials and stock price? Try the links below:

Viveve Medical Inc (VIVE) Stock Price | Nasdaq
Viveve Medical Inc (VIVE) Stock Quote, History and News - Yahoo Finance
Viveve Medical Inc (VIVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!